Back

Feasibility, efficacity and safety of a fast up-titration program of heart failure treatments in real-life practice.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 3 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Laurine Blasi

Toulouse (France)

3 More presentations in this session

Presentation thumbnail
Analysis of the PARAGON-HF study results using win ratio
Doctor W. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial
Doctor A. Foa' (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Real-world impact of early quadruple therapy in HFrEF: a comparative analysis of sequential vs. simultaneous approaches
Mr D. Ferreira (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 3

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
An intensive nurse-led telemedicine program is effective in achieving optimized up-titration of prognostic drugs in heart failure with reduced ejection fraction patients
thumbnail
Congress Presentation
Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital
thumbnail
Congress Presentation
Introduction and optimization of the guideline-directed medical therapy in patients hospitalized for acute heart failure (OPTICARD)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources